OPTOMED.HEOPTOMED.HEHEL
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank79
3Y CAGR+4.0%
5Y CAGR-14.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+4.0%/yr
vs +32.8%/yr prior
5Y CAGR
-14.7%/yr
Recent acceleration
Acceleration
-28.8pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 88.19% |
| Q3 2025 | 36.25% |
| Q2 2025 | -543.94% |
| Q1 2025 | 16.67% |
| Q4 2024 | 122.18% |
| Q3 2024 | -156.07% |
| Q2 2024 | -8.74% |
| Q1 2024 | -12.69% |
| Q4 2023 | -159.58% |
| Q3 2023 | 263.89% |
| Q2 2023 | -6.36% |
| Q1 2023 | -303.67% |
| Q4 2022 | 78.37% |
| Q3 2022 | 47.77% |
| Q2 2022 | -40.26% |
| Q1 2022 | -42.15% |
| Q4 2021 | 36.65% |
| Q3 2021 | 45.55% |
| Q2 2021 | -445.91% |
| Q1 2021 | -167.10% |
| Q4 2020 | 195.75% |
| Q3 2020 | -473.83% |
| Q2 2020 | 103.66% |
| Q1 2020 | -246.00% |
| Q4 2019 | 477.36% |
| Q3 2019 | 31.17% |
| Q2 2019 | -42.86% |
| Q1 2019 | -139.20% |
| Q4 2018 | 5388.46% |
| Q3 2018 | 0.00% |